title: Worsening of calcinosis cutis with teriparatide treatment in two osteoporotic patients.
abstract: We present two cases of patients with systemic autoimmune diseases (one with dermatomyositis and one with CREST syndrome) who presented with a worsening of calcinosis cutis after treatment of osteoporosis with teriparatide. To our knowledge, this association is not described in the literature and might be considered in the spectrum of adverse reactions to teriparatide.
authors.affiliation: Unit of Rheumatology, Fundación Valle del Lili, Cali, Colombia.
authors.forename: A F
authors.initials: AF
authors.lastname: Echeverri
authors.affiliation: Unit of Rheumatology, Fundación Valle del Lili, Cali, Colombia.|Clinical Investigation Institute, Fundación Valle del Lili, Cali, Colombia.
authors.forename: F E
authors.initials: FE
authors.lastname: Ospina
authors.affiliation: Unit of Rheumatology, Fundación Valle del Lili, Cali, Colombia.
authors.forename: C A
authors.initials: CA
authors.lastname: Cañas
authors.affiliation: Unit of Rheumatology, Fundación Valle del Lili, Cali, Colombia.
authors.forename: A
authors.initials: A
authors.lastname: Agualimpia
authors.affiliation: Unit of Rheumatology, Fundación Valle del Lili, Cali, Colombia.|Clinical Investigation Institute, Fundación Valle del Lili, Cali, Colombia.
authors.forename: J P
authors.initials: JP
authors.lastname: Suso
authors.affiliation: Unit of Rheumatology, Fundación Valle del Lili, Cali, Colombia. gtobon1@yahoo.com.|Laboratory of Immunology, Fundación Valle del Lili, Cali, Colombia. gtobon1@yahoo.com.
authors.forename: G J
authors.initials: GJ
authors.lastname: Tobón
authors.affiliation: Unit of Rheumatology, Fundación Valle del Lili, Cali, Colombia.
authors.forename: F
authors.initials: F
authors.lastname: Bonilla-Abadía
mesh_terms: D000368:Aged; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D017675:CREST Syndrome / Q000150:complications; D002114:Calcinosis / Q000139:chemically induced*; D003882:Dermatomyositis / Q000150:complications; D005260:Female; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D012871:Skin Diseases / Q000139:chemically induced*; D019379:Teriparatide / Q000009:adverse effects*
chemical_list: D050071:Bone Density Conservation Agents; D019379:Teriparatide